drugset / Trial / NCT02810873
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Terminated
19 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
National Institutes of Health (NIH) · collab
RandomizedSingle-groupOpen-labelDiagnostic
Summary
This clinical trial studies positron emission tomography imaging in using copper Cu 64 TP3805in patients with breast cancer. Diagnostic procedures, such as positron emission tomography (PET) and positron emission mammography (PEM) scan, using Cu-64-TP3805 may help doctors find and diagnose breast cancer.
Timeline
- Start
- 2008-09
- Primary completion
- 2012-05
- Completion
- 2012-07
Outcome
Outcome not reported
Stopped: “Study terminated by PI”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Copper Cu 64 TP3805 | Diagnostic / imaging agent | — | — |